GC Corp.
SEC Form 4 insider trading activity
GC Corp. has filed 1 SEC Form 4 filing (2 transaction rows) across 1 company, with disclosures dating back to 2026. 1 of those filings fall inside the rolling window. Most recent filing: May 28, 2026.
On the most recent filing, GC Corp. is listed as 10% Owner at Artiva Biotherapeutics, Inc. Inside the rolling window, GC Corp. reported 1 open-market purchase totaling $16.5M in ARTV and no open-market sales.
Companies traded
Other insiders at ARTV
Insider Buying
$16.5M
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has GC Corp. made?
GC Corp. has filed 1 SEC Form 4 filing (2 transaction rows) across 1 company since 2026.
Which companies does GC Corp. trade?
GC Corp. has filed SEC Form 4 disclosures for 1 company, including ARTV.
When was GC Corp.'s most recent SEC Form 4 filing?
GC Corp.'s most recent SEC Form 4 filing on Tracefour is dated May 28, 2026.
What is GC Corp.'s total buy and sell value in the current window?
Inside the rolling retention window, GC Corp. bought $16.5M and sold $0 based on SEC Form 4 filings.
What was GC Corp.'s largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 1,432,291 ARTV shares on 2026-05-11, worth $16.5M, per SEC Form 4 filings.